{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-307773","form_type":"8-K","ticker":"SPRY","cik":"0001671858","company_name":"ARS Pharmaceuticals, Inc.","filed_at":"2026-07-17T20:02:07+00:00","discovered_at":"2026-07-17T20:03:01.524946+00:00","generated_at":"2026-07-17T20:03:05.555964+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"ARS Pharma board member Lowenthal resigns; CMO Tanimoto terminated without cause","bullets":["Richard Lowenthal resigned from the Board effective July 15, 2026, as a condition for severance.","CMO Sarina Tanimoto ceased employment on July 15, 2026, under termination without cause.","Lowenthal receives $217,350 and Tanimoto $111,780 as prorated 2026 target bonus payments.","Severance and bonus payments conditioned on execution of release of claims."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-307773","json":"https://secwatch.observer/filing/0001193125-26-307773.json","markdown":"https://secwatch.observer/filing/0001193125-26-307773.md","text":"https://secwatch.observer/filing/0001193125-26-307773.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1671858/000119312526307773/0001193125-26-307773-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1671858/000119312526307773/d168709d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-17T20:03:05.555964+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}